Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia.
- Resource Type
- journal article
- Source
- Journal of Clinical Oncology; 11/10/2018, Vol. 36 Issue 32, p3192-3202, 12p
- Subject
- Language
- ISSN
- 0732183X